Frontiers in Pharmacology

Formononetin improved healthspan via the P53/P21/CDK4 pathway in SAMP8 mice and DAF-16/SKN-1 signaling pathway in C.elegans

Figure 1 from Frontiers in Pharmacology
Open the figure at full size
Figure 1. Liu et al.
Experiments in miceInterventions

5 months, dose-response, declared no competing interests

The paper

Zunyi Medical University

Frontiers in Pharmacology, 23 Sep 2026

doi.org/10.3389/fphar.2026.1918524PubMed 42846323